Elevated plasma levels of proinflammatory markers, including IL-6, CRP, LPS, and PCT, in GDM-exposed neonates underscore the potential for increased systemic inflammation and increased susceptibility to infections (Aung et al., 2018). Here, IL6 is linked to gestational diabetes.